This report contains market size and forecasts of Oxaliplatin in Global, including the following market information:
Global Oxaliplatin Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Oxaliplatin market was valued at 892.2 million in 2020 and is projected to reach US$ 962.5 million by 2027, at a CAGR of 1.9% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oxaliplatin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oxaliplatin Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Oxaliplatin Market Segment Percentages, By Type, 2020 (%)
Mannitol
Glucose Solution
Lactose Solution
Other

China Oxaliplatin Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Oxaliplatin Market Segment Percentages, By Application, 2020 (%)
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Other

Global Oxaliplatin Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Oxaliplatin Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Oxaliplatin Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Oxaliplatin Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing

1 Introduction to Research & Analysis Reports
1.1 Oxaliplatin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oxaliplatin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oxaliplatin Overall Market Size
2.1 Global Oxaliplatin Market Size: 2021 VS 2027
2.2 Global Oxaliplatin Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oxaliplatin Players in Global Market
3.2 Top Global Oxaliplatin Companies Ranked by Revenue
3.3 Global Oxaliplatin Revenue by Companies
3.4 Top 3 and Top 5 Oxaliplatin Companies in Global Market, by Revenue in 2020
3.5 Global Companies Oxaliplatin Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oxaliplatin Players in Global Market
3.6.1 List of Global Tier 1 Oxaliplatin Companies
3.6.2 List of Global Tier 2 and Tier 3 Oxaliplatin Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oxaliplatin Market Size Markets, 2021 & 2027
4.1.2 Mannitol
4.1.3 Glucose Solution
4.1.4 Lactose Solution
4.1.5 Other
4.2 By Type - Global Oxaliplatin Revenue & Forecasts
4.2.1 By Type - Global Oxaliplatin Revenue, 2016-2021
4.2.2 By Type - Global Oxaliplatin Revenue, 2022-2027
4.2.3 By Type - Global Oxaliplatin Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oxaliplatin Market Size, 2021 & 2027
5.1.2 Colorectal Cancer
5.1.3 Stomach Cancer
5.1.4 Ovarian Cancer
5.1.5 Other
5.2 By Application - Global Oxaliplatin Revenue & Forecasts
5.2.1 By Application - Global Oxaliplatin Revenue, 2016-2021
5.2.2 By Application - Global Oxaliplatin Revenue, 2022-2027
5.2.3 By Application - Global Oxaliplatin Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Oxaliplatin Market Size, 2021 & 2027
6.2 By Region - Global Oxaliplatin Revenue & Forecasts
6.2.1 By Region - Global Oxaliplatin Revenue, 2016-2021
6.2.2 By Region - Global Oxaliplatin Revenue, 2022-2027
6.2.3 By Region - Global Oxaliplatin Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Oxaliplatin Revenue, 2016-2027
6.3.2 US Oxaliplatin Market Size, 2016-2027
6.3.3 Canada Oxaliplatin Market Size, 2016-2027
6.3.4 Mexico Oxaliplatin Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Oxaliplatin Revenue, 2016-2027
6.4.2 Germany Oxaliplatin Market Size, 2016-2027
6.4.3 France Oxaliplatin Market Size, 2016-2027
6.4.4 U.K. Oxaliplatin Market Size, 2016-2027
6.4.5 Italy Oxaliplatin Market Size, 2016-2027
6.4.6 Russia Oxaliplatin Market Size, 2016-2027
6.4.7 Nordic Countries Oxaliplatin Market Size, 2016-2027
6.4.8 Benelux Oxaliplatin Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Oxaliplatin Revenue, 2016-2027
6.5.2 China Oxaliplatin Market Size, 2016-2027
6.5.3 Japan Oxaliplatin Market Size, 2016-2027
6.5.4 South Korea Oxaliplatin Market Size, 2016-2027
6.5.5 Southeast Asia Oxaliplatin Market Size, 2016-2027
6.5.6 India Oxaliplatin Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Oxaliplatin Revenue, 2016-2027
6.6.2 Brazil Oxaliplatin Market Size, 2016-2027
6.6.3 Argentina Oxaliplatin Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oxaliplatin Revenue, 2016-2027
6.7.2 Turkey Oxaliplatin Market Size, 2016-2027
6.7.3 Israel Oxaliplatin Market Size, 2016-2027
6.7.4 Saudi Arabia Oxaliplatin Market Size, 2016-2027
6.7.5 UAE Oxaliplatin Market Size, 2016-2027
7 Players Profiles
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Corporate Summary
7.1.2 Sanofi-Aventis Business Overview
7.1.3 Sanofi-Aventis Oxaliplatin Major Product Offerings
7.1.4 Sanofi-Aventis Oxaliplatin Revenue in Global (2016-2021)
7.1.5 Sanofi-Aventis Key News
7.2 Yakult honsha
7.2.1 Yakult honsha Corporate Summary
7.2.2 Yakult honsha Business Overview
7.2.3 Yakult honsha Oxaliplatin Major Product Offerings
7.2.4 Yakult honsha Oxaliplatin Revenue in Global (2016-2021)
7.2.5 Yakult honsha Key News
7.3 Dr Reddy's laboratories
7.3.1 Dr Reddy's laboratories Corporate Summary
7.3.2 Dr Reddy's laboratories Business Overview
7.3.3 Dr Reddy's laboratories Oxaliplatin Major Product Offerings
7.3.4 Dr Reddy's laboratories Oxaliplatin Revenue in Global (2016-2021)
7.3.5 Dr Reddy's laboratories Key News
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Corporate Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Oxaliplatin Major Product Offerings
7.4.4 Sun Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
7.4.5 Sun Pharmaceutical Key News
7.5 Teva
7.5.1 Teva Corporate Summary
7.5.2 Teva Business Overview
7.5.3 Teva Oxaliplatin Major Product Offerings
7.5.4 Teva Oxaliplatin Revenue in Global (2016-2021)
7.5.5 Teva Key News
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Corporate Summary
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Oxaliplatin Major Product Offerings
7.6.4 Fresenius Kabi Oxaliplatin Revenue in Global (2016-2021)
7.6.5 Fresenius Kabi Key News
7.7 Hospira
7.7.1 Hospira Corporate Summary
7.7.2 Hospira Business Overview
7.7.3 Hospira Oxaliplatin Major Product Offerings
7.4.4 Hospira Oxaliplatin Revenue in Global (2016-2021)
7.7.5 Hospira Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Oxaliplatin Major Product Offerings
7.8.4 Mylan Oxaliplatin Revenue in Global (2016-2021)
7.8.5 Mylan Key News
7.9 Jiangsu Hengrui Medicine
7.9.1 Jiangsu Hengrui Medicine Corporate Summary
7.9.2 Jiangsu Hengrui Medicine Business Overview
7.9.3 Jiangsu Hengrui Medicine Oxaliplatin Major Product Offerings
7.9.4 Jiangsu Hengrui Medicine Oxaliplatin Revenue in Global (2016-2021)
7.9.5 Jiangsu Hengrui Medicine Key News
7.10 Nanjing Pharmaceutical Factory
7.10.1 Nanjing Pharmaceutical Factory Corporate Summary
7.10.2 Nanjing Pharmaceutical Factory Business Overview
7.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Major Product Offerings
7.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Revenue in Global (2016-2021)
7.10.5 Nanjing Pharmaceutical Factory Key News
7.11 Jiangsu Aosaikang Pharmaceutical
7.11.1 Jiangsu Aosaikang Pharmaceutical Corporate Summary
7.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
7.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Major Product Offerings
7.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
7.11.5 Jiangsu Aosaikang Pharmaceutical Key News
7.12 Qilu Pharmaceutical
7.12.1 Qilu Pharmaceutical Corporate Summary
7.12.2 Qilu Pharmaceutical Business Overview
7.12.3 Qilu Pharmaceutical Oxaliplatin Major Product Offerings
7.12.4 Qilu Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
7.12.5 Qilu Pharmaceutical Key News
7.13 Hisun Pharmaceutical
7.13.1 Hisun Pharmaceutical Corporate Summary
7.13.2 Hisun Pharmaceutical Business Overview
7.13.3 Hisun Pharmaceutical Oxaliplatin Major Product Offerings
7.13.4 Hisun Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
7.13.5 Hisun Pharmaceutical Key News
7.14 Lunan Pharmaceutical
7.14.1 Lunan Pharmaceutical Corporate Summary
7.14.2 Lunan Pharmaceutical Business Overview
7.14.3 Lunan Pharmaceutical Oxaliplatin Major Product Offerings
7.14.4 Lunan Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
7.14.5 Lunan Pharmaceutical Key News
7.15 Luoxin
7.15.1 Luoxin Corporate Summary
7.15.2 Luoxin Business Overview
7.15.3 Luoxin Oxaliplatin Major Product Offerings
7.15.4 Luoxin Oxaliplatin Revenue in Global (2016-2021)
7.15.5 Luoxin Key News
7.16 Halfsky Pharmacy
7.16.1 Halfsky Pharmacy Corporate Summary
7.16.2 Halfsky Pharmacy Business Overview
7.16.3 Halfsky Pharmacy Oxaliplatin Major Product Offerings
7.16.4 Halfsky Pharmacy Oxaliplatin Revenue in Global (2016-2021)
7.16.5 Halfsky Pharmacy Key News
7.17 YRPG
7.17.1 YRPG Corporate Summary
7.17.2 YRPG Business Overview
7.17.3 YRPG Oxaliplatin Major Product Offerings
7.17.4 YRPG Oxaliplatin Revenue in Global (2016-2021)
7.17.5 YRPG Key News
7.18 Hainan Jinrui Pharmaceutical
7.18.1 Hainan Jinrui Pharmaceutical Corporate Summary
7.18.2 Hainan Jinrui Pharmaceutical Business Overview
7.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Major Product Offerings
7.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
7.18.5 Hainan Jinrui Pharmaceutical Key News
7.19 Jari Pharmaceutical
7.19.1 Jari Pharmaceutical Corporate Summary
7.19.2 Jari Pharmaceutical Business Overview
7.19.3 Jari Pharmaceutical Oxaliplatin Major Product Offerings
7.19.4 Jari Pharmaceutical Oxaliplatin Revenue in Global (2016-2021)
7.19.5 Jari Pharmaceutical Key News
7.20 Chiatai Tianqing
7.20.1 Chiatai Tianqing Corporate Summary
7.20.2 Chiatai Tianqing Business Overview
7.20.3 Chiatai Tianqing Oxaliplatin Major Product Offerings
7.20.4 Chiatai Tianqing Oxaliplatin Revenue in Global (2016-2021)
7.20.5 Chiatai Tianqing Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer